受精卵検査、拡大を議論　治療法ない遺伝病に―産科婦人科学会

　重い遺伝病の遺伝子などを受精卵の段階で調べ、問題のないものを選ぶ「着床前診断」の拡大を検討している日本産科婦人科学会は２５日、効果的な治療法がなかったり、高度な治療が必要になったりする遺伝病に対象を広げる案を示した。
　学会は同日、社会学者や患者団体関係者、小児や遺伝の専門医らとつくる倫理審議会の第１回会合を開き、案を提示した。
　学会は従来、成人するまでに死亡したり人工呼吸器が必要になったりする重い遺伝病の遺伝子などを持っている場合に限り、着床前診断を容認してきた。今回の案は、効果的な治療がないか、高度な治療しかない、日常生活に大きな影響の出る遺伝病にも対象を広げるとし、年齢の規定もなくした。
　審議会では医師の委員を中心に案に賛成する声が上がったが、社会学者らから「病気の子を産みにくい社会を変えるべきだ」「命の選択をする技術」との指摘もあった。（2020/01/25-20:34）

The Japan Society of Obstetrics and Gynecology on Saturday proposed expanding the scope of cases for which the use of pre-implantation diagnosis is permissible.
   At the first meeting of its ethics committee joined by sociologists, patient support groups, and pediatrics and genetics doctors, the society proposed that pre-implantation diagnosis be applied to patients of hereditary diseases that greatly affect their daily lives, including diseases for which no effective remedy is available or highly advanced therapy is the only way of treatment.
   The organization also proposed removing the age limit for the diagnosis, which is aimed at examining fertilized eggs for genes related to serious inheritable diseases.
   The society has so far tolerated the use of pre-implantation diagnosis only for people having genes of severe hereditary diseases, such as those that could cause patients to die before they grow up or require artificial ventilators.
   At the meeting, the proposal was supported by doctors while sociologists and others express caution. One of the cautious members said, "We should consider changing the current society in which it is difficult to give birth to babies with diseases," and another stated, "Pre-implantation diagnosis is a technology leading to the selection of life."